EUVIMEDSkopri EUVIMED
Beobachtungsstudie

Impact of Tacrolimus Intra‐Patient Variability on Toxicity Development Among Lung Transplant Recipients

Rita Nogueiras-Álvarez iD, Víctor Manuel Mora-Cuesta iD, José Manuel Cifrián-Martínez iD, María Del Mar García-Saiz iD

Basic & Clinical Pharmacology & Toxicology · 2026-05 · 138 (5)

DOI: 10.1111/bcpt.70229 ↗

At a glance

Beobachtungsstudie in Basic & Clinical Pharmacology & Toxicology, published online on 2026-03-26. Written by Rita Nogueiras-Álvarez and 3 co-authors. Institution: Clinical Pharmacology, Osakidetza-Basque Health Service, Galdakao-Usansolo University Hospital, Galdakao, Bizkaia, Spain. Major MEDLINE topics: Tacrolimus, Lung Transplantation, Immunosuppressive Agents, Graft Rejection. 50 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Immunosuppressive treatment helps to reduce the risk of rejection after transplantation. However, it is important to be aware of the potential toxicities that can develop after this therapy initiation. Tacrolimus is currently the calcineurin inhibitor of choice in the post‐transplantation immunosuppressive therapy, and its intra‐patient variability (Tac‐IPV) has been proposed in recent years as a useful biomarker in post‐transplant outcomes. We performed an observational retrospective study in 195 lung transplant recipients to determine the potential impact of Tac‐IPV as a biomarker in the development of cardiovascular toxicities and renal impairment in the post‐transplantation evolution. Different Tac‐IPV calculation measurements were shown to be statistically associated with the development of arterial hypertension de novo in the univariate analysis: the standard deviation ( p = 0.016 for tacrolimus C min values; p = 0.022 for tacrolimus dose‐adjusted values); the coefficient of variation ( p = 0.021 for C min ; p = 0.031 for dose‐adjusted values); and the mean absolute deviation (MAD) ( p = 0.043 for C min ; p = 0.033 for dose‐adjusted values). Those patients with a MAD ≥ 16.47% had a higher risk of renal impairment ( p = 0.045). In our study, different Tac‐IPV measures were associated with arterial hypertension in lung transplantation follow‐up. Patients with a high Tac‐IPV, using the MAD as a measurement, showed a higher risk for renal impairment. No other statistically significant associations were found for the other studied events.

Subjects

MeSH terms (MEDLINE)

TacrolimusLung TransplantationImmunosuppressive AgentsGraft RejectionCalcineurin InhibitorsHumansFemaleRetrospective StudiesMaleMiddle AgedAdultHypertension

Author keywords

arterial hypertensionclinical pharmacologydiabetes mellitushyperlipidaemiaimmunosuppressionlung transplantationrenal impairmenttacrolimustoxicities

Substances

TacrolimusImmunosuppressive AgentsCalcineurin Inhibitors

Authors and institutions

  • Clinical Pharmacology, Osakidetza-Basque Health Service, Galdakao-Usansolo University Hospital, Galdakao, Bizkaia, Spain.
  • Respiratory Department, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain.
  • IDIVAL (Instituto de Investigación Sanitaria Valdecilla), Santander, Cantabria, Spain.
  • University of Cantabria, Santander, Cantabria, Spain.
  • Clinical Pharmacology Department, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain.

ORCID profiles: Rita Nogueiras-Álvarez, Víctor Manuel Mora-Cuesta, José Manuel Cifrián-Martínez, María Del Mar García-Saiz

Cite

APA

Nogueiras-Álvarez, R., Mora-Cuesta, V. M., Cifrián-Martínez, J. M., & García-Saiz, M. D. M. (2026). Impact of Tacrolimus Intra‐Patient Variability on Toxicity Development Among Lung Transplant Recipients. Basic & Clinical Pharmacology & Toxicology, 138(5). https://doi.org/10.1111/bcpt.70229

Vancouver

Nogueiras-Álvarez R, Mora-Cuesta VM, Cifrián-Martínez JM, García-Saiz MDM. Impact of Tacrolimus Intra‐Patient Variability on Toxicity Development Among Lung Transplant Recipients. Basic & Clinical Pharmacology & Toxicology. 2026;138(5). doi:10.1111/bcpt.70229

BibTeX
@article{Nogueiraslvarez2026,
  author = {Nogueiras-Álvarez, Rita and Mora-Cuesta, Víctor Manuel and Cifrián-Martínez, José Manuel and García-Saiz, María Del Mar},
  title = {Impact of Tacrolimus Intra‐Patient Variability on Toxicity Development Among Lung Transplant Recipients},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {138},
  number = {5},
  doi = {10.1111/bcpt.70229}
}
Start for free →